A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.

UNLABELLED:Breast cancer (BC) in young adult patients (YA) has a more aggressive biological behavior and is associated with a worse prognosis than BC arising in middle aged patients (MA). We proposed that differentially expressed miRNAs could regulate genes and proteins underlying aggressive phenoty...

Full description

Bibliographic Details
Main Authors: E P Bastos, H Brentani, C A B Pereira, A Polpo, L Lima, R D Puga, F S Pasini, C A B T Osorio, R A Roela, M I Achatz, A P Trapé, A M Gonzalez-Angulo, M M Brentani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4859528?pdf=render
_version_ 1818838813305208832
author E P Bastos
H Brentani
C A B Pereira
A Polpo
L Lima
R D Puga
F S Pasini
C A B T Osorio
R A Roela
M I Achatz
A P Trapé
A M Gonzalez-Angulo
M M Brentani
author_facet E P Bastos
H Brentani
C A B Pereira
A Polpo
L Lima
R D Puga
F S Pasini
C A B T Osorio
R A Roela
M I Achatz
A P Trapé
A M Gonzalez-Angulo
M M Brentani
author_sort E P Bastos
collection DOAJ
description UNLABELLED:Breast cancer (BC) in young adult patients (YA) has a more aggressive biological behavior and is associated with a worse prognosis than BC arising in middle aged patients (MA). We proposed that differentially expressed miRNAs could regulate genes and proteins underlying aggressive phenotypes of breast tumors in YA patients when compared to those arising in MA patients. OBJECTIVE:Using integrated expression analyses of miRs, their mRNA and protein targets and stromal gene expression, we aimed to identify differentially expressed profiles between tumors from YA-BC and MA-BC. METHODOLOGY AND RESULTS:Samples of ER+ invasive ductal breast carcinomas, divided into two groups: YA-BC (35 years or less) or MA-BC (50-65 years) were evaluated. Screening for BRCA1/2 status according to the BOADICEA program indicated low risk of patients being carriers of these mutations. Aggressive characteristics were more evident in YA-BC versus MA-BC. Performing qPCR, we identified eight miRs differentially expressed (miR-9, 18b, 33b, 106a, 106b, 210, 518a-3p and miR-372) between YA-BC and MA-BC tumors with high confidence statement, which were associated with aggressive clinicopathological characteristics. The expression profiles by microarray identified 602 predicted target genes associated to proliferation, cell cycle and development biological functions. Performing RPPA, 24 target proteins differed between both groups and 21 were interconnected within a network protein-protein interactions associated with proliferation, development and metabolism pathways over represented in YA-BC. Combination of eight mRNA targets or the combination of eight target proteins defined indicators able to classify individual samples into YA-BC or MA-BC groups. Fibroblast-enriched stroma expression profile analysis resulted in 308 stromal genes differentially expressed between YA-BC and MA-BC. CONCLUSION:We defined a set of differentially expressed miRNAs, their mRNAs and protein targets and stromal genes that distinguish early onset from late onset ER positive breast cancers which may be involved with tumor aggressiveness of YA-BC.
first_indexed 2024-12-19T03:44:21Z
format Article
id doaj.art-de1f223a2afd4ac4a2552b0748e14172
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T03:44:21Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-de1f223a2afd4ac4a2552b0748e141722022-12-21T20:37:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015432510.1371/journal.pone.0154325A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.E P BastosH BrentaniC A B PereiraA PolpoL LimaR D PugaF S PasiniC A B T OsorioR A RoelaM I AchatzA P TrapéA M Gonzalez-AnguloM M BrentaniUNLABELLED:Breast cancer (BC) in young adult patients (YA) has a more aggressive biological behavior and is associated with a worse prognosis than BC arising in middle aged patients (MA). We proposed that differentially expressed miRNAs could regulate genes and proteins underlying aggressive phenotypes of breast tumors in YA patients when compared to those arising in MA patients. OBJECTIVE:Using integrated expression analyses of miRs, their mRNA and protein targets and stromal gene expression, we aimed to identify differentially expressed profiles between tumors from YA-BC and MA-BC. METHODOLOGY AND RESULTS:Samples of ER+ invasive ductal breast carcinomas, divided into two groups: YA-BC (35 years or less) or MA-BC (50-65 years) were evaluated. Screening for BRCA1/2 status according to the BOADICEA program indicated low risk of patients being carriers of these mutations. Aggressive characteristics were more evident in YA-BC versus MA-BC. Performing qPCR, we identified eight miRs differentially expressed (miR-9, 18b, 33b, 106a, 106b, 210, 518a-3p and miR-372) between YA-BC and MA-BC tumors with high confidence statement, which were associated with aggressive clinicopathological characteristics. The expression profiles by microarray identified 602 predicted target genes associated to proliferation, cell cycle and development biological functions. Performing RPPA, 24 target proteins differed between both groups and 21 were interconnected within a network protein-protein interactions associated with proliferation, development and metabolism pathways over represented in YA-BC. Combination of eight mRNA targets or the combination of eight target proteins defined indicators able to classify individual samples into YA-BC or MA-BC groups. Fibroblast-enriched stroma expression profile analysis resulted in 308 stromal genes differentially expressed between YA-BC and MA-BC. CONCLUSION:We defined a set of differentially expressed miRNAs, their mRNAs and protein targets and stromal genes that distinguish early onset from late onset ER positive breast cancers which may be involved with tumor aggressiveness of YA-BC.http://europepmc.org/articles/PMC4859528?pdf=render
spellingShingle E P Bastos
H Brentani
C A B Pereira
A Polpo
L Lima
R D Puga
F S Pasini
C A B T Osorio
R A Roela
M I Achatz
A P Trapé
A M Gonzalez-Angulo
M M Brentani
A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
PLoS ONE
title A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
title_full A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
title_fullStr A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
title_full_unstemmed A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
title_short A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
title_sort set of mirnas their gene and protein targets and stromal genes distinguish early from late onset er positive breast cancer
url http://europepmc.org/articles/PMC4859528?pdf=render
work_keys_str_mv AT epbastos asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT hbrentani asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT cabpereira asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT apolpo asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT llima asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT rdpuga asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT fspasini asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT cabtosorio asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT raroela asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT miachatz asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT aptrape asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT amgonzalezangulo asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT mmbrentani asetofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT epbastos setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT hbrentani setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT cabpereira setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT apolpo setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT llima setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT rdpuga setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT fspasini setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT cabtosorio setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT raroela setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT miachatz setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT aptrape setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT amgonzalezangulo setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer
AT mmbrentani setofmirnastheirgeneandproteintargetsandstromalgenesdistinguishearlyfromlateonseterpositivebreastcancer